Seeking Cold Chain Efficiency - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Seeking Cold Chain Efficiency
Medication safety and efficacy depend on maintaining products at the proper temperature.


Pharmaceutical Technology
Volume 37, Issue 2

Going forward

Eventually, temperature-controlled shipping standards will be harmonized internationally. Near term, scrutiny will increase on every point in the supply chain, including mail order pharmacies. In fact, Ellinger of PakSense predicts, "more tracking of products throughout the entire cold-chain continuum—including the 'last mile.'" Bill Hingle, director of marketing at Cryopak, a division of TCP Reliable, agrees, noting that the many variables involved with protecting product to the point of use make the last mile the weakest link in the cold chain.


Cold-chain trends
Hingle also forecasts a shift from looking at packaging costs alone to considering all expenses related to maintaining products at the proper temperature during storage and transport. This change in financial tactics will coincide with a move away from more generic temperature-controlled packaging options to "truly qualified and validated solutions," says Mills of Intelsius.

The stronger emphasis on the big picture will prompt more partnerships among carriers, pharmaceutical manufacturers and distributors, and logistics providers to proactively monitor the cold chain. As a result, we'll see greater use of smart containers that can compensate for unexpected events like summer-time temperatures in February in New York City or a diverted flight that translates into eight extra hours on the tarmac in extreme heat or cold. "You don't want to lose high-value product or product that's in short supply or critically needed," concludes Payne of Intelleflex.

References

1. MHRA, "Good Distribution Practice," http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodDistributionPractice, accessed Jan. 2, 2013.

2. H. Forcinio, Pharm. Tech. 36 (9) 34-36 (2012).

3. A. Montero, P. Mahesh, and K. Maltas, "Case Study: Designing 2–8 C Shippers for International Shipments from US to Latin America," presentation at IQPC's Cold Chain & Temperature Management Global Forum (Chicago, IL, 2012).

4. Cardinal Health, "Cold Chain–Refrigerated Tote Qualification," http://www.cardinalhealth.com/, accessed Jan. 2, 2013.

Cold-chain management resources

Cold Chain IQ, a sub-group of Pharma IQ, http://www.linkedin.com

Cool Chain Association, http://www.coolchain.org

European Union, “Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/C 63/03),” http://ec.europa.eu/health/files/eudralex/vol-4/gdpguidelines1.pdf

Health Canada, “Guidelines for Temperature Control of Drug Products during Storage and Transportation (GUI-0069),” http://www.hc-sc.gc.ca/dhp-mps/compli-conform/gmp-bpf/docs/gui-0069-eng.php

International Air Transport Association, “Air Transport Logistics for Time and Temperature Sensitive Healthcare Products, Chapter 17” in Perishable Cargo Regulations, http://www.iata.org/publications/Pages/perishable-cargo.aspx

ISPE, “Good Practice Guide: Cold Chain Management,” http://www.ISPE.org/Publications

Medicines and Healthcare Products Regulatory Agency, “Good Distribution Practice: Guidance and Legislation,” http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodDistributionPractice/Guidanceandlegislation/index.htm#9

Pharmaceutical Cold Chain Interest Group, http://www.pda.org

Temperature Assurance Group, http://www.linkedin.com

USP General Chapter 659, “Packaging and Storage Requirements,” (will be official in USP 37-NF 32 in May 2014), http://www.usp.org

USP General Chapter 1079, “Good Storage and Shipping Practices” (2012), http://www.usp.org

USP General Chapter 1083, “Good Distribution Practices – Supply Chain Integrity,” (being reworked based on comments received from the Pharmacopeial Forum proposal and a public workshop in May 2012), http://www.usp.org

USP General Chapter 1118, “Monitoring Devices-Time, Temperature, and Humidity” (2013), http://www.usp.org

World Health Organization, “Guidelines on the International Packaging and Shipping of Vaccines,” http://www.who.int/vaccines-documents/DoxGen/H5-CC.htm


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
25%
Oversee medical treatment of patients in the US.
13%
Provide treatment for patients globally.
10%
All of the above.
43%
No government involvement in patient treatment or drug development.
10%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here